[go: up one dir, main page]

RU2004118448A - PHARMACEUTICAL COMPOSITION WITH PROLONGED GLYCLAZIDE RELEASE - Google Patents

PHARMACEUTICAL COMPOSITION WITH PROLONGED GLYCLAZIDE RELEASE Download PDF

Info

Publication number
RU2004118448A
RU2004118448A RU2004118448/15A RU2004118448A RU2004118448A RU 2004118448 A RU2004118448 A RU 2004118448A RU 2004118448/15 A RU2004118448/15 A RU 2004118448/15A RU 2004118448 A RU2004118448 A RU 2004118448A RU 2004118448 A RU2004118448 A RU 2004118448A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
composition according
glyclazide
prolonged
release
Prior art date
Application number
RU2004118448/15A
Other languages
Russian (ru)
Other versions
RU2273482C2 (en
Original Assignee
Открытое Акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") (RU)
Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Открытое Акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") (RU), Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") filed Critical Открытое Акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") (RU)
Priority to RU2004118448/15A priority Critical patent/RU2273482C2/en
Publication of RU2004118448A publication Critical patent/RU2004118448A/en
Application granted granted Critical
Publication of RU2273482C2 publication Critical patent/RU2273482C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (5)

1. Фармацевтическая композиция с пролонгированным высвобождением гликлазида, характеризующаяся тем, что она содержит терапевтически эффективное количество гликлазида и целевые добавки, в качестве которых она содержит гидроксипропилметилцеллюлозу, микрокристаллическую целлюлозу, аэросил и соль стеариновой кислоты в количестве 4,65-6,70 мас. ч./ед. массы действующего вещества.1. A pharmaceutical composition with a sustained release of gliclazide, characterized in that it contains a therapeutically effective amount of gliclazide and target additives, in which it contains hydroxypropylmethyl cellulose, microcrystalline cellulose, aerosil and a stearic acid salt in an amount of 4.65-6.70 wt. h / unit mass of active substance. 2. Фармацевтическая композиция по п.1, отличающаяся тем, что она содержит целевые добавки при следующем соотношении компонентов, мас. ч./ед. массы действующего вещества:2. The pharmaceutical composition according to claim 1, characterized in that it contains the target additives in the following ratio of components, wt. h / unit mass of active substance: ГидроксипропилметилцеллюлозаHydroxypropyl methylcellulose 2,50-3,502,50-3,50 Микрокристаллическая целлюлозаMicrocrystalline cellulose 2,12-3,002.12-3.00 АэросилAerosil 0,01-0,050.01-0.05 Соль стеариновой кислотыStearic acid salt 0,02-0,150.02-0.15
3. Фармацевтическая композиция по пп. 1 и 2, отличающаяся тем, что в качестве соли стеариновой кислоты она содержит магниевую и/или кальциевую соли.3. The pharmaceutical composition according to paragraphs. 1 and 2, characterized in that as the salt of stearic acid, it contains magnesium and / or calcium salts. 4. Фармацевтическая композиция по п.1, отличающаяся тем, что она выполнена в виде твердой лекарственной формы.4. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a solid dosage form. 5. Фармацевтическая композиция по п.4, отличающаяся тем, что она выполнена, преимущественно, в виде таблетки.5. The pharmaceutical composition according to claim 4, characterized in that it is made mainly in the form of tablets.
RU2004118448/15A 2004-06-21 2004-06-21 Pharmaceutical composition with sustained-release of gliclazide RU2273482C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2004118448/15A RU2273482C2 (en) 2004-06-21 2004-06-21 Pharmaceutical composition with sustained-release of gliclazide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004118448/15A RU2273482C2 (en) 2004-06-21 2004-06-21 Pharmaceutical composition with sustained-release of gliclazide

Publications (2)

Publication Number Publication Date
RU2004118448A true RU2004118448A (en) 2006-01-10
RU2273482C2 RU2273482C2 (en) 2006-04-10

Family

ID=35871560

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004118448/15A RU2273482C2 (en) 2004-06-21 2004-06-21 Pharmaceutical composition with sustained-release of gliclazide

Country Status (1)

Country Link
RU (1) RU2273482C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123213A1 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Modified release formulations of gliclazide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2410097C2 (en) * 2008-10-16 2011-01-27 Открытое Акционерное Общество "Татхимфармпрепараты" Modified release dosage form of trimethazidin and method for preparing thereof (versions)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1243A (en) * 1999-02-01 2004-02-02 Servier Lab Core tablet for controlled release of gliclazide after oral administration.
FR2795326B1 (en) * 1999-06-28 2001-08-31 Adir SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123213A1 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Modified release formulations of gliclazide

Also Published As

Publication number Publication date
RU2273482C2 (en) 2006-04-10

Similar Documents

Publication Publication Date Title
JP2025013344A5 (en)
JP2007518760A5 (en)
RU2015151938A (en) TABLETABLE MEDICINE (4'-TRIFFORMETHYLPHENYL) AMID (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID WITH IMPROVED STABILITY
HRP20171917T1 (en) Therapeutic compositions containing macitentan
RU2004118448A (en) PHARMACEUTICAL COMPOSITION WITH PROLONGED GLYCLAZIDE RELEASE
RU2007119641A (en) COMPOSITION INCLUDING ACETAMINOPHEN, CAFFEINE AND OPTIONAL ASPIRINE IN A MIXTURE WITH AN ALKALINE AGENT FOR INCREASING ABSORPTION
RU2008115582A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE
RU2007112544A (en) PHARMACEUTICAL COMPOSITION HAVING ANTI-VESSEL AND PSYCHOTROPIC ACTION
RU2008139377A (en) SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES
RU2004123356A (en) PHARMACEUTICAL COMPOSITION BASED ON AFOBAZOLE
RU2009101126A (en) PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION
RU2007125596A (en) COMBINED TUBERCULOSIS DRUG
RU2004123357A (en) PHARMACEUTICAL COMPOSITION BASED ON NOOPEPT
RU2006116540A (en) SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES
RU2006142336A (en) PHARMACEUTICAL COMPOSITION BASED ON LADASTEN
RU2005110207A (en) MUKOLITIC PHARMACEUTICAL COMPOSITION
RU2009114885A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT
RU2003104272A (en) ANTIFUNGAL PHARMACEUTICAL COMPOSITION
RU2006105104A (en) A MEDICINAL PREPARED WITH AN ANALGESIC, ANTI-DIPLINKING AND PSYCHO-STIMULATING ACTION, AND METHOD FOR PRODUCING IT
RU2010134123A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES
RU2008113043A (en) PHARMACEUTICAL COMPOSITION WITH ANTI-MIRACLE ACTION
RU2005103743A (en) MEDICINAL FORM WITH PREPARED COMBINED MEDICINAL ACTION AND METHOD FOR ITS PRODUCTION
KR100825039B1 (en) Amlodipine maleate tablets with improved stability
RU2011104563A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ARTERIAL HYPERTENSION AND CONSTANT HEART FAILURE AND METHOD FOR ITS PRODUCTION
RU2004138697A (en) AN ANTI-HYPERTENSIVE ACTION MEDICINAL PRODUCT AND METHOD FOR PRODUCING IT

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180622